DK2142533T3 - Imidazolidinonderivater - Google Patents

Imidazolidinonderivater

Info

Publication number: DK2142533T3
Authority: DK; Denmark
Prior art keywords: imidazolidinone derivatives; imidazolidinone; derivatives
Prior art date: 2007-03-30

Application number

DK08717926.3T

Other languages

English (en)

Inventor

Henrietta Dehmlow

Bernd Kuhn

Sander Ulrike Obst

Tanja Schulz-Gasch

Matthew Wright

Stephan Roever

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-30

Filing date

2008-03-18

Publication date

2011-12-12

2008-03-18 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2011-12-12 Application granted granted Critical

2011-12-12 Publication of DK2142533T3 publication Critical patent/DK2142533T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Obesity (AREA)
Virology (AREA)
Neurology (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Ophthalmology & Optometry (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Gastroenterology & Hepatology (AREA)
Cardiology (AREA)

DK08717926.3T 2007-03-30 2008-03-18 Imidazolidinonderivater DK2142533T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07105376		2007-03-30
PCT/EP2008/053192 WO2008119657A1 (en)	2007-03-30	2008-03-18	Imidazolidinone derivatives

Publications (1)

Publication Number	Publication Date
DK2142533T3 true DK2142533T3 (da)	2011-12-12

Family

ID=39661434

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08717926.3T DK2142533T3 (da)	2007-03-30	2008-03-18	Imidazolidinonderivater

Country Status (22)

Country	Link
US (1)	US7625902B2 (da)
EP (1)	EP2142533B1 (da)
JP (1)	JP5165748B2 (da)
KR (1)	KR101171433B1 (da)
CN (1)	CN101641348B (da)
AR (1)	AR065863A1 (da)
AT (1)	ATE533761T1 (da)
AU (1)	AU2008234017B2 (da)
BR (1)	BRPI0809680A2 (da)
CA (1)	CA2681809C (da)
CL (1)	CL2008000875A1 (da)
DK (1)	DK2142533T3 (da)
ES (1)	ES2375586T3 (da)
IL (1)	IL200868A0 (da)
MX (1)	MX2009010567A (da)
PE (1)	PE20090549A1 (da)
PL (1)	PL2142533T3 (da)
PT (1)	PT2142533E (da)
RU (1)	RU2437882C2 (da)
TW (1)	TWI348908B (da)
WO (1)	WO2008119657A1 (da)
ZA (1)	ZA200906467B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2008288537B2 (en) *	2007-08-13	2011-03-24	F. Hoffmann-La Roche Ag	Novel piperazine amide derivatives
EP2242745A1 (de) *	2008-02-07	2010-10-27	Sanofi-Aventis	Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2011157827A1 (de)	2010-06-18	2011-12-22	Sanofi	Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
WO2012033353A2 (ko)	2010-09-07	2012-03-15	서울대학교 산학협력단	세스터터핀 화합물 및 이들 물질의 용도
US20160002188A1 (en)	2013-03-13	2016-01-07	Forma Therapeutics, Inc.	Novel compounds and compositions for inhibition of fasn
TWI744242B (zh)	2015-07-31	2021-11-01	德商安美基研究（慕尼黑）公司	Egfrviii及cd3抗體構築體
EP3373935B1 (en)	2015-11-12	2021-09-01	Merck Sharp & Dohme Corp.	Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use
EA039859B1 (ru)	2016-02-03	2022-03-21	Эмджен Рисерч (Мюник) Гмбх	Биспецифические конструкты антител, связывающие egfrviii и cd3
US11236053B2 (en)	2017-07-26	2022-02-01	Emory University	NADPH oxidase inhibitors and uses thereof
PL3796975T3 (pl)	2018-05-22	2024-02-26	Orsobio, Inc.	Pochodne sulfonyloaminobenzamidu
TWI748194B (zh)	2018-06-28	2021-12-01	德商菲尼克斯Ｆｘｒ有限責任公司	含有雙環核心部分之新穎lxr調節劑
TWI767148B (zh)	2018-10-10	2022-06-11	美商弗瑪治療公司	抑制脂肪酸合成酶(fasn)
US10793554B2 (en)	2018-10-29	2020-10-06	Forma Therapeutics, Inc.	Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone
EP4087651A1 (en) *	2020-01-10	2022-11-16	Uniwersytet Jagiellonski	Aromatic sulphonamides derivatives that inhibits pdi a1, their synthesis and use
EP4087650A1 (en) *	2020-01-10	2022-11-16	Uniwersytet Jagiellonski	Aromatic sulphonamides derivatives that inhibits pdi a1, their synthesis and use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0966462B1 (en) *	1997-02-13	2003-06-11	AstraZeneca AB	Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
US6316503B1 (en) *	1999-03-15	2001-11-13	Tularik Inc.	LXR modulators
WO2001060818A1 (en) *	2000-02-14	2001-08-23	Tularik Inc.	Lxr modulators
ATE283253T1 (de) *	2000-09-18	2004-12-15	Glaxo Group Ltd	Substituierte aminopropoxyarylderivate als lxr agonisten
WO2003099769A1 (en) *	2002-05-24	2003-12-04	Pharmacia Corporation	Anilino liver x-receptor modulators
US20050192286A1 (en) *	2003-10-22	2005-09-01	Neurocrine Biosciences, Inc.	Ligands of melanocortin receptors and compositions and methods related thereto
EP1758882A4 (en) *	2004-06-24	2008-01-23	Incyte Corp	AMID COMPOUNDS AND THEIR USE AS MEDICAMENTS
EP1763502A1 (en)	2004-06-28	2007-03-21	F.Hoffmann-La Roche Ag	Novel hexafluoroisopropanol derivatives
DE102005000666B3 (de) *	2005-01-04	2006-10-05	Sanofi-Aventis Deutschland Gmbh	Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

2008
- 2008-03-18 CA CA2681809A patent/CA2681809C/en not_active Expired - Fee Related
- 2008-03-18 DK DK08717926.3T patent/DK2142533T3/da active
- 2008-03-18 EP EP08717926A patent/EP2142533B1/en not_active Not-in-force
- 2008-03-18 MX MX2009010567A patent/MX2009010567A/es active IP Right Grant
- 2008-03-18 PT PT08717926T patent/PT2142533E/pt unknown
- 2008-03-18 RU RU2009139915/04A patent/RU2437882C2/ru not_active IP Right Cessation
- 2008-03-18 KR KR1020097022619A patent/KR101171433B1/ko not_active IP Right Cessation
- 2008-03-18 JP JP2010501464A patent/JP5165748B2/ja not_active Expired - Fee Related
- 2008-03-18 CN CN200880009826.7A patent/CN101641348B/zh not_active Expired - Fee Related
- 2008-03-18 PL PL08717926T patent/PL2142533T3/pl unknown
- 2008-03-18 ES ES08717926T patent/ES2375586T3/es active Active
- 2008-03-18 WO PCT/EP2008/053192 patent/WO2008119657A1/en active Application Filing
- 2008-03-18 AU AU2008234017A patent/AU2008234017B2/en not_active Ceased
- 2008-03-18 BR BRPI0809680-5A2A patent/BRPI0809680A2/pt not_active IP Right Cessation
- 2008-03-18 AT AT08717926T patent/ATE533761T1/de active
- 2008-03-24 US US12/053,674 patent/US7625902B2/en not_active Expired - Fee Related
- 2008-03-27 AR ARP080101267A patent/AR065863A1/es not_active Application Discontinuation
- 2008-03-27 TW TW097111130A patent/TWI348908B/zh not_active IP Right Cessation
- 2008-03-27 CL CL200800875A patent/CL2008000875A1/es unknown
- 2008-03-27 PE PE2008000551A patent/PE20090549A1/es not_active Application Discontinuation
2009
- 2009-09-10 IL IL200868A patent/IL200868A0/en unknown
- 2009-09-16 ZA ZA200906467A patent/ZA200906467B/xx unknown

Also Published As

Publication number	Publication date
CN101641348B (zh)	2014-09-10
AU2008234017B2 (en)	2011-09-22
AR065863A1 (es)	2009-07-08
EP2142533A1 (en)	2010-01-13
PE20090549A1 (es)	2009-05-09
WO2008119657A1 (en)	2008-10-09
EP2142533B1 (en)	2011-11-16
CA2681809A1 (en)	2008-10-09
JP2010523514A (ja)	2010-07-15
TW200848046A (en)	2008-12-16
CL2008000875A1 (es)	2008-10-03
AU2008234017A1 (en)	2008-10-09
IL200868A0 (en)	2010-05-17
CN101641348A (zh)	2010-02-03
PL2142533T3 (pl)	2012-04-30
RU2437882C2 (ru)	2011-12-27
BRPI0809680A2 (pt)	2014-10-07
CA2681809C (en)	2012-06-05
RU2009139915A (ru)	2011-05-10
JP5165748B2 (ja)	2013-03-21
PT2142533E (pt)	2012-01-19
MX2009010567A (es)	2009-10-22
US20080242677A1 (en)	2008-10-02
ZA200906467B (en)	2010-05-26
ES2375586T3 (es)	2012-03-02
KR101171433B1 (ko)	2012-08-06
US7625902B2 (en)	2009-12-01
TWI348908B (en)	2011-09-21
ATE533761T1 (de)	2011-12-15
KR20090130090A (ko)	2009-12-17

Publication	Publication Date	Title
LTPA2020528I1 (lt)	2020-09-25	Benzimidazolo dariniai
CY2022017I1 (el)	2023-01-05	Παραγωγα πυριδαζινονης
DK2209786T3 (da)	2013-06-03	Pyrimidinsubstituerede purinderivater
BRPI0820112A2 (pt)	2015-05-05	Derivados de isoxazol-piridina
BRPI0809992A2 (pt)	2014-10-14	Derivados de pirrolopirimidina
BRPI0820113A2 (pt)	2015-05-05	Derivados de isoxazolo-piridazina
BRPI0813836A2 (pt)	2015-01-06	Derivados pirazólicos
ATE533761T1 (de)	2011-12-15	Imidazolidinonderivate
BRPI0812155A2 (pt)	2019-09-24	derivados de espiroindolinona
DK2308877T3 (da)	2014-04-22	Imidazopyridin-2-on-derivater
BRPI0817935A2 (pt)	2015-04-07	Derivados de biarila
ATE518837T1 (de)	2011-08-15	Indazolamidderivate
DK2016080T3 (da)	2010-11-22	Dihydropyrazolopyrimidinon-derivater
ATE483711T1 (de)	2010-10-15	Spiroindolinonderivate
ATE469905T1 (de)	2010-06-15	Pyridopyrimidinonderivate
ATE512135T1 (de)	2011-06-15	Spiroindolinonderivate
BRPI0814236A2 (pt)	2015-01-06	Derivados de quinazolinamida
DK2035394T3 (da)	2009-10-05	2-pyrazincarboxamidderivater
BRPI0820649A2 (pt)	2015-06-16	Derivados de isoxazalo-pirazina
DK2152370T3 (da)	2011-08-15	Aryletherpyridazinonderivater
DK2275414T3 (da)	2015-06-22	Cyclopentylacrylamidderivat
ATE545635T1 (de)	2012-03-15	Substituierte n-oxidpyrazinderivate
DK2086968T3 (da)	2012-03-19	5-hydroxymethyl-oxazolidin-2-on-derivater
ATE519760T1 (de)	2011-08-15	Isoxazolimidazolderivate
ATE534634T1 (de)	2011-12-15	2-phenyl-4-cyclopropyl-pyrimidinderivate